
Oct 29, 2026
Press releaseFlagship Pioneering Forms Etcelera to Move Drug Discovery from Probability to Prediction
Etcelera unites the platform technologies of Cellarity, Etiome, and Empress Therapeutics with Flagship Pioneering's proprietary AI capabilities to scale causal intelligence in human biologyVeteran CEO and accomplished company builder Ad Rawcliffe to lead new entityCAMBRIDGE, Mass., Oct. 29, 2026 /PRNewswire/ -- Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced the formation of Etcelera, a company created by the merger of the platforms


